Your browser doesn't support javascript.
loading
Laparoscopic adjustable gastric banding and hypoglycemia.
Bairdain, Sigrid; Cleary, Mark; Lien, Chueh; Vernon, Ashley H; Linden, Bradley C; Lautz, David B.
Affiliation
  • Bairdain S; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Case Rep Endocrinol ; 2013: 671848, 2013.
Article in En | MEDLINE | ID: mdl-24198980
Obesity is commonplace, and surgical treatment usually includes Roux-en-Y gastric bypasses (RYGBs). RYGBs have the most documented side effects including vitamin deficiencies, rebound weight gain, and symptomatic hypoglycemia; fewer series exist describing hypoglycemia following other bariatric operations. We reviewed all patients undergoing laparoscopic adjustable gastric banding (LAGB) at our institution between 2008 and 2012. Three patients were identified to have symptomatic hypoglycemia following LAGB. Mean time from surgery was 33 months (range 14-45 months), and mean weight loss was 32.7 kg (range 15.9-43.1 kg). None of the patients had preexisting diabetes. Therefore, symptomatic hypoglycemia should be investigated irrespective of bariatric operation.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Case Rep Endocrinol Year: 2013 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Case Rep Endocrinol Year: 2013 Document type: Article Affiliation country: United States Country of publication: United States